Evidence map›Paper›PMID 37068079›Full record

ArticlePLoS genetics2023

A frame-shift mutation in COMTD1 is associated with impaired pheomelanin pigmentation in chicken.

Huijuan Bi, Jonas Tranell, Dawn C Harper, Weifeng Lin, Jingyi Li, Anders R Hellström, Mårten Larsson, Carl-Johan Rubin, Chao Wang, Shumaila Sayyab and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 5 countries.

Huijuan BiScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Jonas TranellScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Dawn C HarperDepartment of Pathology & Laboratory Medicine and Department of Physiology, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America.
Weifeng LinDepartment of Chemistry - BMC, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-8330-7072
Jingyi LiKey Laboratory of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Anders R HellströmScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Mårten LarssonScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Carl-Johan RubinScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Chao WangScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-3936-4023
Shumaila SayyabDepartment of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Susanne KerjeScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Bertrand Bed'homUniversité Paris-Saclay, INRAE, AgroParisTech, GABI, F-78350 Jouy-en-Josas, France.ORCID 0000-0002-0825-0886
David GourichonINRAE, PEAT, Nouzilly, France.
Shosuke ItoInstitute for Melanin Chemistry, Fujita Health University, Toyoake, Aichi, Japan.ORCID 0000-0001-9182-5144
Kazumasa WakamatsuInstitute for Melanin Chemistry, Fujita Health University, Toyoake, Aichi, Japan.ORCID 0000-0003-1748-9001
Michèle Tixier-BoichardUniversité Paris-Saclay, INRAE, AgroParisTech, GABI, F-78350 Jouy-en-Josas, France.
Michael S MarksDepartment of Pathology & Laboratory Medicine and Department of Physiology, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America.
Daniel GlobischDepartment of Chemistry - BMC, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-4526-5788
Leif AnderssonScience for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-4085-6968
Uppsala University · SEAgroParisTech · FRChildren's Hospital of Philadelphia · USFujita Health University · JPHuazhong Agricultural University · CNInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRSwedish University of Agricultural Sciences · SE

Funding

Genetic and molecular basis for variation in human skin pigmentationR01AR076241 · NIAMS · CHILDREN'S HOSP OF PHILADELPHIA · PI MARKS, MICHAEL S, OANCEA, ELENA · 2020 to 2024
$5.5M
NIAMS NIH HHS R01 AR076241
6 · The paper itself

Abstract

The biochemical pathway regulating the synthesis of yellow/red pheomelanin is less well characterized than the synthesis of black/brown eumelanin. Inhibitor of gold (IG phenotype) is a plumage colour variant in chicken that provides an opportunity to further explore this pathway since the recessive allele (IG) at this locus is associated with a defect in the production of pheomelanin. IG/IG homozygotes display a marked dilution of red pheomelanin pigmentation, whilst black pigmentation (eumelanin) is only slightly affected. Here we show that a 2-base pair insertion (frame-shift mutation) in the 5th exon of the Catechol-O-methyltransferase containing domain 1 gene (COMTD1), expected to cause a complete or partial loss-of-function of the COMTD1 enzyme, shows complete concordance with the IG phenotype within and across breeds. We show that the COMTD1 protein is localized to mitochondria in pigment cells. Knockout of Comtd1 in a mouse melanocytic cell line results in a reduction in pheomelanin metabolites and significant alterations in metabolites of glutamate/glutathione, riboflavin, and the tricarboxylic acid cycle. Furthermore, COMTD1 overexpression enhanced cellular proliferation following chemical-induced transfection, a potential inducer of oxidative stress. These observations suggest that COMTD1 plays a protective role for melanocytes against oxidative stress and that this supports their ability to produce pheomelanin.

Indexed as

Catechol O-MethyltransferaseChickensAnimalsFrameshift MutationMelaninsMiceMice, KnockoutPigmentationCatechol O-MethyltransferaseMelaninspheomelanin

Identifiers

PMID37068079
PMCPMC10138217
OpenAlexW4366084310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.